サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1697122

充填仕上げ医薬品受託製造の世界市場：業界分析、規模、シェア、成長、動向、予測（2025年～2032年）

Fill-finish Pharmaceutical Contract Manufacturing Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

出版日
ページ情報
英文 250 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
充填仕上げ医薬品受託製造の世界市場：業界分析、規模、シェア、成長、動向、予測（2025年～2032年）
出版日: 2025年03月31日
発行: Persistence Market Research
ページ情報: 英文 250 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の充填仕上げ医薬品受託製造の市場規模は、2025年に105億9,000万米ドルになるとみられ、2025年～2032年の予測期間に9.1%のCAGRで拡大し、2032年には194億8,000万米ドルに達すると予測されています。

注射薬、生物製剤、ワクチンの効率的かつ無菌的な包装を保証する充填仕上げ受託製造は、製薬業界で重要な役割を果たしています。このプロセスでは、バイアル、シリンジ、カートリッジに製剤を充填し、厳格な規制ガイドラインの下で密封して薬剤の完全性を維持します。同市場は、製薬会社、バイオテクノロジー企業、開発・製造受託機関（CDMO）向けに、医薬品の製剤から最終的な包装まで、エンドツーエンドのサービスを提供しています。市場拡大の背景には、生物製剤に対する需要の高まり、アウトソーシング動向の増加、品質保証とコンプライアンスを重視する規制要件の厳格化があります。

世界の充填仕上げ医薬品受託製造市場は、慢性疾患の蔓延による生物製剤やバイオシミラーなどの注射剤需要の増加など、いくつかの主要な要因によって牽引されています。業務効率の向上とコスト削減を目的とした製薬企業やバイオテクノロジー企業によるアウトソーシングモデルの採用が増加していることも、市場の成長をさらに後押ししています。ロボットによる自動化、シングルユースシステム、高度な無菌充填技術の統合などの技術の進歩により、製造効率と無菌性が向上しています。さらに、COVID-19パンデミックはワクチン製造の需要を加速させ、世界のサプライチェーンのニーズを満たすために充填仕上げ受託製造業者への依存を高めることにつながっています。

有望な成長が見込まれますが、医薬品中間体受託製造市場は、高い設備投資要件、厳格な規制遵守、サプライチェーンの混乱に関連する課題に直面しています。最新鋭の充填仕上げ施設を設立するには多額の資金が必要となるため、新規参入企業は制限されます。さらに、FDA、EMA、WHOなどの機関による厳しい規制により、厳格な品質管理とバリデーション・プロセスが必要となり、業務が複雑化します。サプライチェーンの制約、特に特殊な賦形剤、バイアル、シリンジは、生産スケジュールに影響を与え、コストを上昇させる可能性があります。こうした課題に対処するには、製造インフラ、品質保証システム、サプライチェーンの強靭性に対する戦略的投資が必要です。

充填仕上げ医薬品受託製造市場は、バイオ医薬品と個別化医療のパイプラインの増加により、大きな機会をもたらしています。自己投与療法のためのプレフィルドシリンジや自動注射器の採用が増加していることは、受託製造業者に有利な成長の道を提供しています。さらに、細胞治療や遺伝子治療の台頭は、特殊な充填仕上げソリューションの需要を促進し、CDMOにサービスポートフォリオの拡大を促しています。新興市場、特にアジア太平洋とラテンアメリカでは医薬品製造への投資が増加しており、充填仕上げサービスプロバイダーに新たなビジネスチャンスをもたらしています。連続生産、人工知能を活用した品質管理、リアルタイム監視システムなどの技術革新を活用することで、生産能力を強化し、市場拡大を促進することができます。

当レポートでは、世界の医充填仕上げ医薬品受託製造市場について調査し、製品別、分子別、最終用途別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の範囲と定義
  • 市場力学
  • マクロ経済要因
  • COVID-19の影響分析
  • 予測要因- 関連性と影響

第3章 付加価値の洞察

  • 製品採用分析
  • 規制状況
  • バリューチェーン分析
  • 主要な取引と合併
  • PESTLE分析
  • ポーターのファイブフォース分析

第4章 価格動向分析、2019年～2032年

  • 主なハイライト
  • 製品価格に影響を与える主な要因
  • 製品別の価格分析
  • 地域別の価格と製品の好み

第5章 世界の充填仕上げ医薬品受託製造市場の見通し

  • 主なハイライト
  • 市場規模分析と予測
    • 過去の市場規模分析、2019年～2024年
    • 現在の市場規模の分析と予測、2025年～2032年
  • 世界の充填仕上げ医薬品受託製造市場の見通し：製品別
  • 市場の魅力分析：製品別
  • 世界の充填仕上げ医薬品受託製造市場の見通し：分子別
  • 市場の魅力分析：分子別
  • 世界の充填仕上げ医薬品受託製造市場の見通し：最終用途別
  • 市場の魅力分析：最終用途別

第6章 世界の充填仕上げ医薬品受託製造市場の見通し：地域別

  • 主なハイライト
  • 2019～2024年までの地域別市場規模と数量（個）分析
  • 現在の市場規模と数量の分析と予測、地域別、2025年～2032年
    • 北米
    • 欧州
    • 東アジア
    • 南アジアとオセアニア
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力分析：地域年

第7章 北米の充填仕上げ医薬品受託製造市場の見通し

第8章 欧州の充填仕上げ医薬品受託製造市場の見通し

第9章 東アジアの充填仕上げ医薬品受託製造市場の見通し

第10章 南アジアおよびオセアニアの充填仕上げ医薬品受託製造市場の見通し

第11章 ラテンアメリカの充填仕上げ医薬品受託製造市場の見通し

第12章 中東・アフリカの充填仕上げ医薬品受託製造市場の見通し

第13章 競合情勢

  • 市場シェア分析、2025年
  • 市場構造
  • 企業プロファイル（詳細- 概要、財務、戦略、最近の動向）
    • Lonza
    • Baxter
    • Recipharm AB
    • Sartorius AG
    • Catalent, Inc.
    • Societal CDMO
    • Eurofins Scientific
    • Symbiosis Pharmaceutical Services Ltd
    • MabPlex International Co. Ltd.
    • Fresenius Kabi, USA LLC
    • Thermo Fisher Scientific Inc.
    • Boehringer Ingelheim International GmbH

第14章 付録

目次
Product Code: PMRREP13351

Persistence Market Research has recently released a comprehensive report on the worldwide market for Fill-finish Pharmaceutical Contract Manufacturing. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global Fill-finish Pharmaceutical Contract Manufacturing Market from 2025 to 2032.

Key Insights:

  • Fill-finish Pharmaceutical Contract Manufacturing Market Size (2025E): US$ 10.59 Bn
  • Projected Market Value (2032F): US$ 19.48 Bn
  • Global Market Growth Rate (CAGR 2025 to 2032): 9.1%

Fill-finish Pharmaceutical Contract Manufacturing Market - Report Scope:

Fill-finish contract manufacturing plays a critical role in the pharmaceutical industry, ensuring the efficient and sterile packaging of injectable drugs, biologics, and vaccines. This process involves filling vials, syringes, and cartridges with drug formulations and sealing them under strict regulatory guidelines to maintain drug integrity. The market caters to pharmaceutical companies, biotechnology firms, and contract development and manufacturing organizations (CDMOs), offering end-to-end services from drug formulation to final packaging. Market expansion is fueled by the rising demand for biologics, increasing outsourcing trends, and stringent regulatory requirements emphasizing quality assurance and compliance.

Market Growth Drivers:

The global fill-finish pharmaceutical contract manufacturing market is driven by several key factors, including the growing prevalence of chronic diseases, which is increasing the demand for injectable drugs such as biologics and biosimilars. The rising adoption of outsourcing models by pharmaceutical and biotechnology companies to enhance operational efficiency and reduce costs further propels market growth. Technological advancements, such as the integration of robotic automation, single-use systems, and advanced aseptic filling technologies, are improving manufacturing efficiency and sterility. Additionally, the COVID-19 pandemic has accelerated the demand for vaccine production, leading to an increased reliance on fill-finish contract manufacturers to meet global supply chain needs.

Market Restraints:

Despite promising growth prospects, the fill-finish pharmaceutical contract manufacturing market faces challenges related to high capital investment requirements, stringent regulatory compliance, and supply chain disruptions. Establishing state-of-the-art fill-finish facilities demands significant financial resources, limiting the entry of new market players. Additionally, strict regulations imposed by agencies such as the FDA, EMA, and WHO necessitate rigorous quality control and validation processes, increasing operational complexities. Supply chain constraints, particularly for specialized excipients, vials, and syringes, can impact production timelines and escalate costs. Addressing these challenges requires strategic investments in manufacturing infrastructure, quality assurance systems, and supply chain resilience.

Market Opportunities:

The fill-finish pharmaceutical contract manufacturing market presents significant opportunities driven by the growing pipeline of biopharmaceuticals and personalized medicine. The increasing adoption of prefilled syringes and auto-injectors for self-administration therapies offers lucrative growth avenues for contract manufacturers. Moreover, the rise of cell and gene therapies is driving demand for specialized fill-finish solutions, encouraging CDMOs to expand their service portfolios. Emerging markets, particularly in Asia-Pacific and Latin America, are witnessing rising investments in pharmaceutical manufacturing, creating new opportunities for fill-finish service providers. Leveraging technological innovations such as continuous manufacturing, artificial intelligence-driven quality control, and real-time monitoring systems can enhance production capabilities and drive market expansion.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the fill-finish pharmaceutical contract manufacturing market globally?
  • Which drug types and packaging formats are witnessing the highest demand in fill-finish services?
  • How are technological advancements reshaping the competitive landscape of the fill-finish market?
  • Who are the key players contributing to the market, and what strategies are they employing to maintain a competitive edge?
  • What are the emerging trends and future prospects in the global fill-finish pharmaceutical contract manufacturing industry?

Competitive Intelligence and Business Strategy:

Leading players in the global fill-finish pharmaceutical contract manufacturing market, including Lonza Group, Catalent Inc., Recipharm AB, Samsung Biologics, and WuXi AppTec, focus on capacity expansion, strategic partnerships, and advanced automation to gain a competitive edge. These companies are investing in high-speed filling lines, isolator-based aseptic filling technologies, and single-use filling systems to enhance production efficiency and sterility. Collaborations with pharmaceutical innovators and regulatory agencies facilitate compliance with global quality standards, ensuring seamless product approvals. Additionally, increased emphasis on sustainability initiatives, such as green manufacturing and eco-friendly packaging solutions, is gaining traction in the evolving fill-finish landscape.

Key Companies Profiled:

  • Lonza Group
  • Catalent Inc.
  • Recipharm AB
  • Samsung Biologics
  • WuXi AppTec
  • Baxter BioPharma Solutions
  • Vetter Pharma International GmbH
  • CordenPharma International
  • Piramal Pharma Solutions
  • Ajinomoto Bio-Pharma Services

Fill-finish Pharmaceutical Contract Manufacturing Market Segmentation

By Product

  • Prefilled Syringes
  • Vials
  • Cartridges

By Molecule

  • Large Molecules
  • Small Molecules

By End Use

  • Biopharmaceutical Companies
  • Pharmaceutical Companies

By Region

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Middle East and Africa
  • Latin America

Table of Contents

1. Executive Summary

  • 1.1. Global Fill-finish Pharmaceutical Contract Manufacturing Market Snapshot, 2025-2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product Adoption Analysis
  • 3.2. Regulatory Landscape
  • 3.3. Value Chain Analysis
  • 3.4. Key Deals and Mergers
  • 3.5. PESTLE Analysis
  • 3.6. Porter's Five Force Analysis

4. Price Trend Analysis, 2019-2032

  • 4.1. Key Highlights
  • 4.2. Key Factors Impacting Product Prices
  • 4.3. Pricing Analysis By Product
  • 4.4. Regional Prices and Product Preferences

5. Global Fill-finish Pharmaceutical Contract Manufacturing Market Outlook:

  • 5.1. Key Highlights
    • 5.1.1. Market Volume (Units) Projections
    • 5.1.2. Market Size (US$ Mn) and Y-o-Y Growth
    • 5.1.3. Absolute $ Opportunity
  • 5.2. Market Size (US$ Mn) Analysis and Forecast
    • 5.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
    • 5.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2025-2032
  • 5.3. Global Fill-finish Pharmaceutical Contract Manufacturing Market Outlook: Product
    • 5.3.1. Introduction / Key Findings
    • 5.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Product, 2019-2024
    • 5.3.3. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
      • 5.3.3.1. Prefilled Syringes
      • 5.3.3.2. Vials
      • 5.3.3.3. Cartridges
  • 5.4. Market Attractiveness Analysis: Product
  • 5.5. Global Fill-finish Pharmaceutical Contract Manufacturing Market Outlook: Molecule
    • 5.5.1. Introduction / Key Findings
    • 5.5.2. Historical Market Size (US$ Mn) Analysis, By Molecule, 2019-2024
    • 5.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Molecule, 2025-2032
      • 5.5.3.1. Large Molecules
      • 5.5.3.2. Small Molecules
  • 5.6. Market Attractiveness Analysis: Molecule
  • 5.7. Global Fill-finish Pharmaceutical Contract Manufacturing Market Outlook: End Use
    • 5.7.1. Introduction / Key Findings
    • 5.7.2. Historical Market Size (US$ Mn) Analysis, By End Use, 2019-2024
    • 5.7.3. Current Market Size (US$ Mn) Analysis and Forecast, By End Use, 2025-2032
      • 5.7.3.1. Biopharmaceutical Companies
      • 5.7.3.2. Pharmaceutical Companies
  • 5.8. Market Attractiveness Analysis: End Use

6. Global Fill-finish Pharmaceutical Contract Manufacturing Market Outlook: Region

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Region, 2019-2024
  • 6.3. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Region, 2025-2032
    • 6.3.1. North America
    • 6.3.2. Europe
    • 6.3.3. East Asia
    • 6.3.4. South Asia and Oceania
    • 6.3.5. Latin America
    • 6.3.6. Middle East & Africa
  • 6.4. Market Attractiveness Analysis: Region

7. North America Fill-finish Pharmaceutical Contract Manufacturing Market Outlook:

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Market, 2019-2024
    • 7.2.1. By Country
    • 7.2.2. By Product
    • 7.2.3. By Molecule
    • 7.2.4. By End Use
  • 7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. U.S.
    • 7.3.2. Canada
  • 7.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 7.4.1. Prefilled Syringes
    • 7.4.2. Vials
    • 7.4.3. Cartridges
  • 7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Molecule, 2025-2032
    • 7.5.1. Large Molecules
    • 7.5.2. Small Molecules
  • 7.6. Current Market Size (US$ Mn) Analysis and Forecast, By End Use, 2025-2032
    • 7.6.1. Biopharmaceutical Companies
    • 7.6.2. Pharmaceutical Companies
  • 7.7. Market Attractiveness Analysis

8. Europe Fill-finish Pharmaceutical Contract Manufacturing Market Outlook:

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Market, 2019-2024
    • 8.2.1. By Country
    • 8.2.2. By Product
    • 8.2.3. By Molecule
    • 8.2.4. By End Use
  • 8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. Germany
    • 8.3.2. France
    • 8.3.3. U.K.
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Russia
    • 8.3.7. Turkey
    • 8.3.8. Rest of Europe
  • 8.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 8.4.1. Prefilled Syringes
    • 8.4.2. Vials
    • 8.4.3. Cartridges
  • 8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Molecule, 2025-2032
    • 8.5.1. Large Molecules
    • 8.5.2. Small Molecules
  • 8.6. Current Market Size (US$ Mn) Analysis and Forecast, By End Use, 2025-2032
    • 8.6.1. Biopharmaceutical Companies
    • 8.6.2. Pharmaceutical Companies
  • 8.7. Market Attractiveness Analysis

9. East Asia Fill-finish Pharmaceutical Contract Manufacturing Market Outlook:

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Market, 2019-2024
    • 9.2.1. By Country
    • 9.2.2. By Product
    • 9.2.3. By Molecule
    • 9.2.4. By End Use
  • 9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. South Korea
  • 9.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 9.4.1. Prefilled Syringes
    • 9.4.2. Vials
    • 9.4.3. Cartridges
  • 9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Molecule, 2025-2032
    • 9.5.1. Large Molecules
    • 9.5.2. Small Molecules
  • 9.6. Current Market Size (US$ Mn) Analysis and Forecast, By End Use, 2025-2032
    • 9.6.1. Biopharmaceutical Companies
    • 9.6.2. Pharmaceutical Companies
  • 9.7. Market Attractiveness Analysis

10. South Asia & Oceania Fill-finish Pharmaceutical Contract Manufacturing Market Outlook:

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Market, 2019-2024
    • 10.2.1. By Country
    • 10.2.2. By Product
    • 10.2.3. By Molecule
    • 10.2.4. By End Use
  • 10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. India
    • 10.3.2. Southeast Asia
    • 10.3.3. ANZ
    • 10.3.4. Rest of South Asia & Oceania
  • 10.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 10.4.1. Prefilled Syringes
    • 10.4.2. Vials
    • 10.4.3. Cartridges
  • 10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Molecule, 2025-2032
    • 10.5.1. Large Molecules
    • 10.5.2. Small Molecules
  • 10.6. Current Market Size (US$ Mn) Analysis and Forecast, By End Use, 2025-2032
    • 10.6.1. Biopharmaceutical Companies
    • 10.6.2. Pharmaceutical Companies
  • 10.7. Market Attractiveness Analysis

11. Latin America Fill-finish Pharmaceutical Contract Manufacturing Market Outlook:

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Market, 2019-2024
    • 11.2.1. By Country
    • 11.2.2. By Product
    • 11.2.3. By Molecule
    • 11.2.4. By End Use
  • 11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. Brazil
    • 11.3.2. Mexico
    • 11.3.3. Rest of Latin America
  • 11.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 11.4.1. Prefilled Syringes
    • 11.4.2. Vials
    • 11.4.3. Cartridges
  • 11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Molecule, 2025-2032
    • 11.5.1. Large Molecules
    • 11.5.2. Small Molecules
  • 11.6. Current Market Size (US$ Mn) Analysis and Forecast, By End Use, 2025-2032
    • 11.6.1. Biopharmaceutical Companies
    • 11.6.2. Pharmaceutical Companies
  • 11.7. Market Attractiveness Analysis

12. Middle East & Africa Fill-finish Pharmaceutical Contract Manufacturing Market Outlook:

  • 12.1. Key Highlights
  • 12.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Market, 2019-2024
    • 12.2.1. By Country
    • 12.2.2. By Product
    • 12.2.3. By Molecule
    • 12.2.4. By End Use
  • 12.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 12.3.1. GCC Countries
    • 12.3.2. Egypt
    • 12.3.3. South Africa
    • 12.3.4. Northern Africa
    • 12.3.5. Rest of Middle East & Africa
  • 12.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 12.4.1. Prefilled Syringes
    • 12.4.2. Vials
    • 12.4.3. Cartridges
  • 12.5. Current Market Size (US$ Mn) Analysis and Forecast, By Molecule, 2025-2032
    • 12.5.1. Large Molecules
    • 12.5.2. Small Molecules
  • 12.6. Current Market Size (US$ Mn) Analysis and Forecast, By End Use, 2025-2032
    • 12.6.1. Biopharmaceutical Companies
    • 12.6.2. Pharmaceutical Companies
  • 12.7. Market Attractiveness Analysis

13. Competition Landscape

  • 13.1. Market Share Analysis, 2025
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping By Market
    • 13.2.2. Competition Dashboard
  • 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.3.1. Lonza
      • 13.3.1.1. Overview
      • 13.3.1.2. Segments and Product Types
      • 13.3.1.3. Key Financials
      • 13.3.1.4. Market Developments
      • 13.3.1.5. Market Strategy
    • 13.3.2. Baxter
    • 13.3.3. Recipharm AB
    • 13.3.4. Sartorius AG
    • 13.3.5. Catalent, Inc.
    • 13.3.6. Societal CDMO
    • 13.3.7. Eurofins Scientific
    • 13.3.8. Symbiosis Pharmaceutical Services Ltd
    • 13.3.9. MabPlex International Co. Ltd.
    • 13.3.10. Fresenius Kabi, USA LLC
    • 13.3.11. Thermo Fisher Scientific Inc.
    • 13.3.12. Boehringer Ingelheim International GmbH

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations